Gene panels are specialized diagnostic tools used to assess multiple genes at once for mutations related to diseases such as cancer, cardiomyopathy, and others. Gene panels enable the users to obtain results at a reduced cost and time. Gene panels are useful in sequencing genes such as BRCA1 to detect mutations that may lead to cancer. DNA sample from blood, muscle or saliva can be used in gene panel testing. Low muscle tone, epilepsy, and short stature are few conditions which can be diagnosed using gene panel tests. Rapid research in DNA sequencing technology has led to the advancement of gene panels making them more efficient, economical, and flexible.
Market Dynamics
Market players are conducting clinical trials for exploring the potential uses of gene panels for diagnosis of a number of genetic disorders, which could contribute to the growth of the gene panel market over the forecast period. For instance, in November 2020 Bordeaux University Hospital, France, initiated an observational clinical study for implementation of a next generation sequencing gene panel for diagnosis of incomplete forms of albinism. This study identifies the usability of NGS gene panel in overcoming the challenges faced in identification of ocular albinism as it does not show many observable ophthalmic signs. This study comprises of 100 participants and is expected to be completed by March 2022.
Market players are focusing on launch of products, which is expected to strengthen their position in the global gene panel market. For instance, in June 2018, Thermo Fisher Scientific Inc., an American scientific instrumentation company, launched Ion AmpliSeq HD technology as an amplicon-based library for targeted next gene sequencing, it enables the user to customize one’s own gene panel by selecting the appropriate gene sequences from the gene library which are associated with a particular disease and detect low-frequency alleles in tumor RNA or DNA.
Key features of the study:
- This report provides an in-depth analysis of global gene panel market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global gene panel market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., BGI, GENEWIZ, Inc., GATC Biotech, Novogene Co., Ltd., QIAGEN, Integrated DNA Technologies, Inc., Illumina Inc., Agilent Technologies, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, Personalis Inc., GeneDx Inc., and Invitae Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global gene panel market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the gene panel market
Detailed Segmentation:
- Global Gene Panel Market, By Technique:
- Amplicon-Based
- Hybridization-Based
- Global Gene Panel Market, By Design:
- Predesigned Gene Panels
- Customized Gene Panels
- Global Gene Panel Market, By Application:
- Pharmacogenetics
- Diagnosis of Congenital Disorders
- Cancer Risk Assessment
- Others
- Global Gene Panel Market, By End User:
- Research and Academic Institutes
- Hospital and Diagnostic Laboratories
- Biotechnology and Pharmaceutical Companies
- Global Gene Panel Market, By Region:
- North America
- By Technique:
- Amplicon-Based
- Hybridization-Based
- By Design:
- Predesigned Gene Panels
- Customized Gene Panels
- By Application:
- Pharmacogenetics
- Diagnosis of Congenital Disorders
- Cancer Risk Assessment
- Others
- By End User:
- Research and Academic Institutes
- Hospital and Diagnostic Laboratories
- Biotechnology and Pharmaceutical Companies
- By Country:
- Latin America
- By Technique:
- Amplicon-Based
- Hybridization-Based
- By Design:
- Predesigned Gene Panels
- Customized Gene Panels
- By Application:
- Pharmacogenetics
- Diagnosis of Congenital Disorders
- Cancer Risk Assessment
- Others
- By End User:
- Research and Academic Institutes
- Hospital and Diagnostic Laboratories
- Biotechnology and Pharmaceutical Companies
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Technique:
- Amplicon-Based
- Hybridization-Based
- By Design:
- Predesigned Gene Panels
- Customized Gene Panels
- By Application:
- Pharmacogenetics
- Diagnosis of Congenital Disorders
- Cancer Risk Assessment
- Others
- By End User:
- Research and Academic Institutes
- Hospital and Diagnostic Laboratories
- Biotechnology and Pharmaceutical Companies
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Technique:
- Amplicon-Based
- Hybridization-Based
- By Design:
- Predesigned Gene Panels
- Customized Gene Panels
- By Application:
- Pharmacogenetics
- Diagnosis of Congenital Disorders
- Cancer Risk Assessment
- Others
- By End User:
- Research and Academic Institutes
- Hospital and Diagnostic Laboratories
- Biotechnology and Pharmaceutical Companies
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Technique:
- Amplicon-Based
- Hybridization-Based
- By Design:
- Predesigned Gene Panels
- Customized Gene Panels
- By Application:
- Pharmacogenetics
- Diagnosis of Congenital Disorders
- Cancer Risk Assessment
- Others
- By End User:
- Research and Academic Institutes
- Hospital and Diagnostic Laboratories
- Biotechnology and Pharmaceutical Companies
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Technique:
- Amplicon-Based
- Hybridization-Based
- By Design:
- Predesigned Gene Panels
- Customized Gene Panels
- By Application:
- Pharmacogenetics
- Diagnosis of Congenital Disorders
- Cancer Risk Assessment
- Others
- By End User:
- Research and Academic Institutes
- Hospital and Diagnostic Laboratories
- Biotechnology and Pharmaceutical Companies
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Thermo Fisher Scientific Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- BGI
- GENEWIZ, Inc.
- GATC Biotech
- Novogene Co., Ltd.
- QIAGEN
- Integrated DNA Technologies, Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Eurofins Scientific
- Hoffmann-La Roche Ltd
- Personalis Inc.
- GeneDx Inc.
- Invitae Corporation
“*” marked represents similar segmentation in other categories in the respective section.
